Medical Condition News

RSS

Researchers discover mechanism that regulates metabolism

The protein complex mTORC1 is a central regulator of cell metabolism. In the active state, it stimulates anabolic processes and increases the production and storage of proteins and lipids. Researchers from the German Leibniz Institute for Age Research in Jena and the Dutch Ageing Institute ERIBA in Groningen discovered a mechanism how mTORC1 regulates metabolism: It controls the expression of a specific variant of the transcriptional regulator C/EBPβ.

29 Jun 2015

Clinical data demonstrates safe administration of Pexa-Vec in patients with metastatic colorectal cancer

SillaJen, Inc., a private clinical-stage biotherapeutics company focused on the development of oncolytic immunotherapy products for cancer, today announced a publication of data demonstrating that in a Phase Ib trial of Pexa-Vec, patients received multiple bi-weekly doses of its lead product Pexa-Vec, representing the first report of multiple intravenous administrations of an oncolytic vaccinia.

29 Jun 2015

Synthetic Biologics announces initiation of SYN-010 Phase 2 clinical trial for treatment of IBS-C

Synthetic Biologics, Inc., a clinical-stage company focused on developing therapeutics to protect the microbiome while targeting pathogen-specific diseases, reported the initiation of a Phase 2 clinical trial of its proprietary SYN-010 for the treatment of irritable bowel syndrome with constipation (IBS-C).

29 Jun 2015

Global GBM therapeutics market to expand at CAGR of 10.9% to $623 million by 2020

According to analysis from business intelligence provider GBI Research - Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2020 - the value of the global Glioblastoma Multiforme (GBM) treatment market will expand at a rapid Compound Annual Growth Rate (CAGR) of 10.9%, from $301 million in 2013 to $623 million by 2020.

29 Jun 2015

Can-Fite reports further progress in continuing preclinical program of CF602 sexual dysfunction drug

Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, today reported further progress in its continuing preclinical program of its CF602 drug candidate as the Company prepares to file an investigational new drug (IND) application with the U.S. Food and Drug Administration to allow the initiation of a Phase I clinical study.

29 Jun 2015

People with specific gene variant at greater risk of developing depressions

People born with a particular gene variant have a greater risk of developing depressions, a recent study from the Department of Psychology at The University of Oslo shows.

29 Jun 2015

Study opens up new line of research into origin of digestive diseases

There are numerous studies related to the absorption of nutrients from the stomach since understanding what happens in our digestive system is crucial, for example, in order to be able to avoid in the future some of the diseases that affect part of the population to a lesser or greater extent.

29 Jun 2015

Canadian Partnership Against Cancer launches landmark health data portal

A landmark research portal that includes health and biological data from 300,000 Canadians — nearly one in every 50 individuals between the ages of 35 and 69 – is being launched today by the Canadian Partnership Against Cancer (the Partnership).

29 Jun 2015

New survey sheds light on the way Americans think about their brain health, lifestyle habits

Is your brain important to you? Do you know how to keep it healthy? According to a recent survey conducted by Reader’s Digest in partnership with the Alzheimer’s Association, 91 percent of people believe they can reduce their risk of cognitive decline, but they have misconceptions about ways to keep their brains healthy.

29 Jun 2015

Cosmederm Bioscience expands TriCalm's line of anti-itch products to further benefit sufferers of itch

Cosmederm Bioscience, Inc. today announced the expansion of its itch-relief product line, TriCalm, with the new TriCalm Clinical Repair Cream and TriCalm Extra Strength Spray. Following the success of the company's initial product, TriCalm Hydrogel, these two new offerings strategically expand the brand's line of steroid-free, anti-itch products to further benefit sufferers of itch.

29 Jun 2015

Scientists identify association between coronary heart disease and osteoporosis

University of Southampton scientists have discovered a link between coronary heart disease and osteoporosis, suggesting both conditions could have similar causes.

29 Jun 2015

NGS technology helps identify new mitochondrial disease gene

Next Generation Sequencing (NGS) technology offers an incredible opportunity for the rapid and relatively low-cost characterization of individual genomes, giving us a chance to make a substantial leap ahead in the molecular dissection of all mitochondrial disorders in humans.

27 Jun 2015

Study proposes use of soft computing solutions to predict survival in multiple trauma patients

The NUP/UPNA-Public University of Navarre has developed a piece of work that applies soft computing solutions to predicting survival in multiple trauma patients.

27 Jun 2015

Two physician-scientists in search for better Alzheimer's disease treatment

Two of the nation's leading physician-scientists in the search to better understand and treat Alzheimer's disease - William Mobley, MD, PhD, and Michael Rafii, MD, PhD - have been named interim co-directors of the Alzheimer's Disease Cooperative Study (ADCS), a major initiative formed in 1991 as a cooperative agreement between the National Institute on Aging (NIA) and the University of California, San Diego.

27 Jun 2015

Implementation of public health strategies can improve survival rates of cardiac arrest in US

The Institute of Medicine Committee on the Treatment of Cardiac Arrest is announcing results of a new report that examines current statistics and survival rates of cardiac arrest in the United States, assesses evidence on existing lifesaving therapies, and recommends public health strategies that – if implemented – will improve cardiac arrest survival rates. Additionally, the report explores cardiopulmonary resuscitation (CPR) and the use of

27 Jun 2015

Neuralstem's HK532-IGF-1 neural stem cells therapy for Alzheimer's disease presented at ISSCR Annual Meeting

Neuralstem, Inc., a biopharmaceutical company using neural stem cell technology to develop small molecule and cell therapy treatments for central nervous system diseases, announced that the poster "Human Neural Stem Cells Expressing IGF-1: A Novel Cellular Therapy for Alzheimer's Disease" was presented yesterday at the International Society for Stem Cell Research (ISSCR) Annual Meeting in Stockholm, Sweden.

27 Jun 2015

Study shows wide geographic variation in use of 'clotbuster' for stroke treatment

It looks like a crazy quilt spread over the continent. But a new map of emergency stroke care in America shows just how much of a patchwork system we still have for delivering the most effective stroke treatment.

27 Jun 2015

CTCA at Western begins Phase Ib/II trial of new immunotherapy treatment for cancer patients

Cancer Treatment Centers of America at Western Regional Medical Center in Goodyear, Arizona, has begun a new Phase Ib/II clinical trial using a new immunotherapy treatment for patients with advanced kidney, non-small cell lung cancer, pancreatic cancer and colorectal carcinoma.

27 Jun 2015

Amy Schumer promises 'disappointing lap dance' for winner of TrainWreck Premiere contest to support MS research

Amy Schumer, writer and star of the upcoming comedy, TrainWreck, has promised a 'disappointing lap dance' for the winner of Universal's TrainWreck Premiere Experience hosted on CrowdRise to benefit the National Multiple Sclerosis (MS) Society, an organization that is very dear to her heart.

27 Jun 2015

The Mary Kay Foundation awards $1.3 million grant to advance cancer research and discovery

With more than 800,000 new cases of cancer among women in the United States expected this year, according to the American Cancer Society, almost everyone is touched by the disease.

27 Jun 2015

Medical Condition News

Researchers discover mechanism that regulates metabolism

Clinical data demonstrates safe administration of Pexa-Vec in patients with metastatic colorectal cancer

Synthetic Biologics announces initiation of SYN-010 Phase 2 clinical trial for treatment of IBS-C

Global GBM therapeutics market to expand at CAGR of 10.9% to $623 million by 2020

Can-Fite reports further progress in continuing preclinical program of CF602 sexual dysfunction drug

People with specific gene variant at greater risk of developing depressions

Study opens up new line of research into origin of digestive diseases

Canadian Partnership Against Cancer launches landmark health data portal

New survey sheds light on the way Americans think about their brain health, lifestyle habits

Cosmederm Bioscience expands TriCalm's line of anti-itch products to further benefit sufferers of itch

Scientists identify association between coronary heart disease and osteoporosis

NGS technology helps identify new mitochondrial disease gene

Study proposes use of soft computing solutions to predict survival in multiple trauma patients

Two physician-scientists in search for better Alzheimer's disease treatment

Implementation of public health strategies can improve survival rates of cardiac arrest in US

Neuralstem's HK532-IGF-1 neural stem cells therapy for Alzheimer's disease presented at ISSCR Annual Meeting

Study shows wide geographic variation in use of 'clotbuster' for stroke treatment

CTCA at Western begins Phase Ib/II trial of new immunotherapy treatment for cancer patients

Amy Schumer promises 'disappointing lap dance' for winner of TrainWreck Premiere contest to support MS research

The Mary Kay Foundation awards $1.3 million grant to advance cancer research and discovery

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News